Rift Valley Fever (RVF) is a viral zoonotic disease and has been a CEPI priority since 2019. Find out more about RVF and CEPI's R&D efforts in this disease area here: Rift Valley Fever on CEPI.net
Events
Upcoming Events
Future events will be added here
Past Events
Rift Valley Fever Workshop
The CEPI RVF team recently hosted a workshop in Nairobi, Kenya. This 2-day meeting was attended by 60+ public health and animal health experts, researchers, epidemiologists, modelers, regulators, funders, and decision-makers (from across Africa, the Middle East and Europe) to discuss advances and gaps in epidemiology and modelling specifically relevant to human RVF vaccine development. View the meeting report here: RVF workshop report
Rift Valley Fever Webinar
This Epidemiology and Modelling for Vaccine Development webinar provided an overview of what is known about RVF epidemiology, and where knowledge gaps impede the development of RVF vaccines for human use. During the webinar CEPI announced the launch of a Call for Proposals to address these knowledge gaps.
Funding Opportunities
Rift Valley Fever Call for Proposal
CEPI's Calls for Proposals invite innovators worldwide to apply to their scientific programmes to advance the development and manufacture of vaccines, enable further scientific progress, and refine tools against epidemic and pandemic threats. The CfP for RVF supports new or existing RVF Epidemiology and Modelling consortia to answer key research gaps on the feasibility of RVF vaccine efficacy studies using existing data and/or samples.
Resources and Publications
CEPI publications and resources
• Gerken, Keli N., et al. "Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021." PLoS neglected tropical diseases 16.1 (2022): e0009852.
• Petrova, Velislava, et al. "Rift valley fever: diagnostic challenges and investment needs for vaccine development." BMJ Global Health 5.8 (2020): e002694.
